ATE309257T1 - METHOD FOR PRODUCING AMINE-PLATINE COMPLEXES - Google Patents

METHOD FOR PRODUCING AMINE-PLATINE COMPLEXES

Info

Publication number
ATE309257T1
ATE309257T1 AT00918620T AT00918620T ATE309257T1 AT E309257 T1 ATE309257 T1 AT E309257T1 AT 00918620 T AT00918620 T AT 00918620T AT 00918620 T AT00918620 T AT 00918620T AT E309257 T1 ATE309257 T1 AT E309257T1
Authority
AT
Austria
Prior art keywords
platine
complexes
producing amine
amine
producing
Prior art date
Application number
AT00918620T
Other languages
German (de)
Inventor
Ernest S Y Wong
Christen M Giandomenico
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of ATE309257T1 publication Critical patent/ATE309257T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00918620T 1999-04-13 2000-04-11 METHOD FOR PRODUCING AMINE-PLATINE COMPLEXES ATE309257T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12893999P 1999-04-13 1999-04-13
PCT/CA2000/000385 WO2000061590A1 (en) 1999-04-13 2000-04-11 Process for preparing amine platinum complexes

Publications (1)

Publication Number Publication Date
ATE309257T1 true ATE309257T1 (en) 2005-11-15

Family

ID=22437722

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918620T ATE309257T1 (en) 1999-04-13 2000-04-11 METHOD FOR PRODUCING AMINE-PLATINE COMPLEXES

Country Status (32)

Country Link
US (1) US6518428B1 (en)
EP (1) EP1165576B1 (en)
JP (1) JP4756669B2 (en)
KR (1) KR100711955B1 (en)
CN (3) CN1916009B (en)
AR (1) AR043084A1 (en)
AT (1) ATE309257T1 (en)
AU (1) AU770006B2 (en)
BG (1) BG65429B1 (en)
BR (1) BR0009780B1 (en)
CA (1) CA2368849C (en)
CY (1) CY1104965T1 (en)
CZ (1) CZ303156B6 (en)
DE (1) DE60023859T2 (en)
DK (1) DK1165576T3 (en)
EE (1) EE04747B1 (en)
ES (1) ES2253214T3 (en)
HK (1) HK1039336B (en)
HU (1) HUP0200748A3 (en)
IL (1) IL145671A0 (en)
IS (1) IS2711B3 (en)
MX (1) MXPA01010430A (en)
MY (1) MY122706A (en)
NO (1) NO330429B1 (en)
NZ (1) NZ514736A (en)
PL (1) PL202731B1 (en)
RU (1) RU2245340C2 (en)
SK (1) SK286374B6 (en)
TW (1) TWI289565B (en)
UA (1) UA71614C2 (en)
WO (1) WO2000061590A1 (en)
ZA (1) ZA200107965B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
DK1165576T3 (en) 1999-04-13 2006-03-27 Anormed Inc Process for the preparation of amine-platinum complexes
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6806289B1 (en) * 2000-07-14 2004-10-19 Stephen J. Lippard Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
US6894049B1 (en) * 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
WO2005077385A2 (en) 2004-02-18 2005-08-25 Gpc Biotech Ag Methods for treating resistant or refractory tumors
CZ2004964A3 (en) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Peroral pharmaceutical composition for targeted transport of platinum complex into colorectal region, process for its preparation and the composition for use as medicament
ES2257178B1 (en) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid PLATINUM COMPOUNDS OF FORMULA TRANS- (PTC12 (ISOPROPYLAMINE) (4- (HYDROXIMETHYL) -PIRIDINE)) AND TRANS- (PTC12 (ISOPROPYLAMINE) (3-HYDROXIMETHYL) -PIRIDINE AND ITS APPLICATION AS ANTITUMORAL PHARMACO.
RU2298556C1 (en) * 2005-11-17 2007-05-10 Общество с ограниченной ответственностью "ЦитоСтарт" Cis-cis-[4-nitraminopyridin-n]tetrachloroplatinum (iv) trimethylolaminomethane salt and method for its preparing
RU2309158C1 (en) * 2006-03-27 2007-10-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Method for production of cis-dichloroamminisopropylamine platinum(ii)
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
EP2178893A4 (en) * 2007-07-16 2012-09-19 Poniard Pharmaceuticals Inc ORAL FORMULATIONS FOR PICOPLATIN
WO2009099649A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
US20120123121A1 (en) * 2009-06-12 2012-05-17 Poniard Pharmaceuticals, Inc. Synthesis of picoplatin
RU2451010C1 (en) * 2011-01-11 2012-05-20 Закрытое Акционерное Общество "Ива Фарм" Palladium-copper catalysts for homogeneous selective oxidation of thiol groups, combination and composition based on said catalysts and therapeutic treatment method
CN105254679B (en) * 2013-11-19 2018-05-15 辽宁大学 Single 6- (azacyclo- substitution) anthraquinone platinous chloride complex and its preparation method and application
CN103860539B (en) * 2014-04-14 2016-02-10 于迎涛 A kind of Pt(IV with mixing axial part) kind anti-cancer drugs thing and preparation method
CN104231000A (en) * 2014-08-20 2014-12-24 山东铂源药业有限公司 Synthesis method of antitumor drug Picoplatin
US10987353B2 (en) 2016-05-04 2021-04-27 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
KR102137669B1 (en) * 2019-08-05 2020-07-27 한국과학기술연구원 Catalyst for synthesizing methanol or precursor thereof, manufacturing method thereof and process of preparing methanol or precursor thereof by using the same
CN115955962B (en) 2020-07-08 2024-07-12 代顿治疗股份公司 Satraplatin for the treatment of lymphoma
CN113402565B (en) * 2021-06-16 2023-07-28 中国人民解放军空军军医大学 Tetravalent platinum complex containing posaconazole, preparation method and application thereof
AU2022430214A1 (en) 2022-01-07 2024-08-15 Pharma& Schweiz Gmbh Treating haematological malignancies by means of satraplatin

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329299A (en) * 1979-08-23 1982-05-11 Johnson, Matthey & Co., Limited Composition of matter containing platinum
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
DE3582961D1 (en) * 1984-06-27 1991-07-04 Johnson Matthey Plc PLATINO COORDINATION CONNECTIONS.
US5244919A (en) 1988-02-02 1993-09-14 Johnson Matthey, Inc. Pt(IV) complexes as anti-tumor agents
SU1790190A1 (en) * 1990-08-08 1996-04-27 Ленинградский химико-фармацевтический институт Cis-chlorodiamine-1,3-dimethylxanthine platinum (ii) chloride dihydrate
GB9105037D0 (en) 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
RU2050361C1 (en) * 1991-12-23 1995-12-20 Юрий Михайлович Островский Pentachlorplatinate(iv) of 4-methyl -3-[(2- methyl-4-oxy-5- pirimidimyl) methyl}-5-(2-oxyethyl thiazole having antitumor activity
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US5547982A (en) * 1995-02-27 1996-08-20 Johnson Matthey, Inc. Anti-tumor platinum complexes
RU2089555C1 (en) * 1995-05-04 1997-09-10 Новосибирский институт биоорганической химии СО РАН Bisimidazole-(1,10)-phenenthroline platinum (iii) dichloride showing cytostatic antitumor activity
KR20010112343A (en) 1999-03-19 2001-12-20 추후제출 Pharmaceutical compositions comprising metal complexes
DK1165576T3 (en) 1999-04-13 2006-03-27 Anormed Inc Process for the preparation of amine-platinum complexes

Also Published As

Publication number Publication date
AU3951000A (en) 2000-11-14
EE04747B1 (en) 2006-12-15
EE200100536A (en) 2003-02-17
JP4756669B2 (en) 2011-08-24
DK1165576T3 (en) 2006-03-27
IS6092A (en) 2001-09-28
IS2709B (en) 2011-01-15
IS2711B3 (en) 2011-01-15
HK1039336B (en) 2006-01-27
CZ20013648A3 (en) 2002-02-13
ES2253214T3 (en) 2006-06-01
CN1916009A (en) 2007-02-21
IL145671A0 (en) 2002-06-30
MXPA01010430A (en) 2002-03-27
BR0009780B1 (en) 2013-09-24
HK1039336A1 (en) 2002-04-19
HUP0200748A2 (en) 2002-07-29
BG65429B1 (en) 2008-07-31
AR043084A1 (en) 2005-07-20
CY1104965T1 (en) 2010-03-03
JP2002541263A (en) 2002-12-03
NO20014957D0 (en) 2001-10-12
CN1350540A (en) 2002-05-22
MY122706A (en) 2006-04-29
CA2368849A1 (en) 2000-10-19
UA71614C2 (en) 2004-12-15
RU2245340C2 (en) 2005-01-27
HK1100562A1 (en) 2007-09-21
EP1165576A1 (en) 2002-01-02
NZ514736A (en) 2004-01-30
CA2368849C (en) 2011-01-25
EP1165576B1 (en) 2005-11-09
CN1847253A (en) 2006-10-18
NO330429B1 (en) 2011-04-11
ZA200107965B (en) 2003-01-02
DE60023859D1 (en) 2005-12-15
US6518428B1 (en) 2003-02-11
CN1916009B (en) 2010-12-15
CZ303156B6 (en) 2012-05-09
KR100711955B1 (en) 2007-05-02
TWI289565B (en) 2007-11-11
PL351612A1 (en) 2003-05-05
BR0009780A (en) 2002-01-02
DE60023859T2 (en) 2006-08-03
SK14682001A3 (en) 2002-01-07
AU770006B2 (en) 2004-02-12
WO2000061590A1 (en) 2000-10-19
SK286374B6 (en) 2008-08-05
NO20014957L (en) 2001-12-03
PL202731B1 (en) 2009-07-31
CN100460412C (en) 2009-02-11
CN1250559C (en) 2006-04-12
KR20020018189A (en) 2002-03-07
HUP0200748A3 (en) 2010-01-28
BG106090A (en) 2002-06-28

Similar Documents

Publication Publication Date Title
DE60023859D1 (en) METHOD FOR PRODUCING AMIN-PLATINUM COMPLEXES
DE60005779D1 (en) METHOD FOR PRODUCING POLYARYLATES
DE69911398D1 (en) METHOD FOR PRODUCING 4-AMINODIPHENYLAMINES
DE50010110D1 (en) METHOD FOR PRODUCING PLATE-MOLDED PRODUCTS
DE60007874D1 (en) METHOD FOR PRODUCING 3-HYDROXYPROPANAL
DE60003264D1 (en) METHOD FOR PRODUCING GLYCERYLETHERS
DE69906593D1 (en) METHOD FOR PRODUCING 8-CHINOLINOLATO METAL COMPLEXES
DE69934332D1 (en) METHOD FOR PRODUCING POLYOLEFINES
DE60006219D1 (en) CONTINUOUS PROCESS FOR PRODUCING DIACETOXYBUTEN
DE50006772D1 (en) METHOD FOR PRODUCING OXINDOLS
DE59901552D1 (en) METHOD FOR PRODUCING POLYALKYLENARYLATES
DE69910995D1 (en) METHOD FOR PRODUCING FLUOROCOLATES
EP1208106A4 (en) METHOD FOR PRODUCING AMINOPROPYL- OR AMINOALKYL-UNTIONALIZED POLYALKYL- OR ARYL-SILOXANES
DE60010683D1 (en) METHOD FOR PRODUCING POLYKETONES
DE69934913D1 (en) METHOD FOR PRODUCING FUNCTIONALIZED POLYPHENYLENETHERS
DE69934334D1 (en) METHOD FOR PRODUCING POLYOLEFINES
DE50001895D1 (en) METHOD FOR PRODUCING PHOSPHONOMETHYLGLYCIN
DE60001902D1 (en) METHOD FOR PRODUCING TITANIUM COMPLEXES
DE50002226D1 (en) METHOD FOR PRODUCING N-PHOSPHONOMETHYLGLYCINE
ATE260884T1 (en) METHOD FOR PRODUCING CARBONYL FLUORIDE
ATE233238T1 (en) METHOD FOR PRODUCING 3-ACYL-INDOLENE
ATE267839T1 (en) METHOD FOR PRODUCING CYCLO-(ASP-DPHE-NMEVAL-ARG-GLY)
DE69901192D1 (en) METHOD FOR PRODUCING CYCLOPROPANMETHYLAMINE
DE69934258D1 (en) METHOD FOR PRODUCING POLYOLEFINES
ATA45299A (en) METHOD FOR PRODUCING OXCARBAZEPINE

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165576

Country of ref document: EP